|
|
Top 10 Holdings as of February 28, 2010
| CLP Holdings, Ltd. |
Utilities |
China/Hong Kong |
2.6% |
| Hongkong Land CB 2005, Ltd., Cnv., 2.750%, 12/21/2012 |
Financials |
China/Hong Kong |
2.5% |
| Keppel Corp., Ltd. |
Industrials |
Singapore |
2.3% |
| HSBC Holdings PLC |
Financials |
United Kingdom |
2.2% |
| Taiwan Semiconductor Manufacturing Co., Ltd. |
Information Technology |
Taiwan |
2.2% |
| Shandong Weigao Group Medical Polymer Co., Ltd. |
Health Care |
China/Hong Kong |
2.1% |
| Japan Real Estate Investment Corp., REIT |
Financials |
Japan |
2.1% |
| Hang Lung Properties, Ltd. |
Financials |
China/Hong Kong |
2.1% |
| Rafflesia Capital, Ltd., Cnv., 1.250%, 10/04/2011 |
Telecom Services |
Malaysia |
2.1% |
| Hisamitsu Pharmaceutical Co., Inc. |
Health Care |
Japan |
2.1% |
| 22.3% |
Top 10 holdings may combine more than one security from the same issuer.
|
Portfolio Data as of December 31, 2009
Sector Allocation (%)a |
| Financials |
27.9 |
31.7 |
-3.8 |
| Industrials |
15.3 |
10.1 |
5.2 |
| Information Technology |
13.0 |
19.2 |
-6.2 |
| Telecom Services |
12.4 |
6.7 |
5.7 |
| Consumer Discretionary |
8.7 |
7.2 |
1.5 |
| Consumer Staples |
5.9
|
4.3 |
1.6 |
| Utilities |
5.0 |
3.9 |
1.1 |
| Health Care |
4.8 |
0.5 |
4.3 |
| Energy |
2.0 |
8.3 |
-6.3 |
| Unclassified |
1.5 |
0.0 |
1.5 |
| Materials |
0.7 |
8.1 |
-7.4 |
Cash, Cash Equivalents
and Other |
2.8 |
0.0 |
2.8 |
Sector data based on MSCI’s revised Global Industry Classification Standards. For more details, visit www.msci.com.
Source: FactSet
Research Systems. |
Country Allocation (%)a |
| China/Hong Kong |
32.0 |
37.2 |
-5.2 |
| Singapore |
15.5 |
6.9 |
8.6 |
| Japan |
10.0 |
0.0 |
10.0 |
| South Korea |
9.0 |
18.8 |
-9.8 |
| India |
8.3 |
11.0 |
-2.7 |
| Taiwan |
6.1 |
16.8 |
-10.7 |
| Malaysia |
5.1 |
3.9 |
1.2 |
| Thailand |
2.6 |
2.0 |
0.6 |
| United Kingdom |
2.3 |
0.0 |
2.3 |
| Indonesia |
2.3 |
2.8 |
-0.5 |
| Australia |
1.8 |
0.0 |
1.8 |
| Philippines |
1.3 |
0.6 |
0.7 |
| Vietnam |
0.9 |
0.0 |
0.9 |
Cash, Cash Equivalents
and Other |
2.8 |
0.0 |
2.8 |
| Source: FactSet Research Systems. |
Market Cap Exposure (%)a,b |
| Large cap (over $5 billion) |
51.7 |
77.5 |
-25.8 |
| Mid cap ($1 - $5 billion) |
31.4 |
21.7 |
9.7 |
| Small cap (under $1 billion) |
12.6 |
0.8 |
11.8 |
| Unclassified |
1.5 |
0.0 |
1.5 |
Cash, Cash Equivalents
and Other |
2.8 |
0.0 |
2.8 |
| Source:
FactSet Research Systems. |
Breakdown by Security Type (%)a |
| Common Equities and ADRs |
64.7 |
| Convertible Bonds |
26.4 |
| Preferred Stocks |
3.1 |
| Government Bonds |
1.5 |
| Corporate Bonds |
1.4 |
| Warrants |
0.2 |
Cash, Cash Equivalents
and Other |
2.8 |
|
Portfolio Characteristics |
| Number of securities |
83 |
| Weighted average market cap |
$20.6 bil |
| Source: FactSet Research
Systems, PNC Global Investment Servicing, Inc
|
| |
|
|
^ As of April 29, 2008, the primary benchmark for
the Matthews Asian Growth and Income Fund became
the MSCI All Country
Asia ex Japan Index to reflect more closely the group of countries in which the
portfolio invests. Previously, the MSCI Far
East ex Japan Index served as the Fund’s primary benchmark. The MSCI All Country
Asia ex Japan Index is a free float adjusted,
market capitalization-weighted index of the stockmarkets of China, Hong Kong,
India, Indonesia,Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand.
It is not possible to invest directly in an index. Source: FactSet Research Systems,
PNC Global
Investment Servicing, Inc.
a Percentage values in data are rounded to the nearest tenth of one percent; the values may not sum to 100% due to marginal rounding errors.
b Equity market cap of issuer.
The information contained in this document does not, in any way, constitute investment advice. It should not be assumed that any investment will be profitable or will equal the performance of the portfolios or any securities or any sectors mentioned herein. The information does not constitute a recommendation to buy or sell any securities mentioned. Information on this document is from sources considered reliable, but no representation or warranty is made as to its completeness or accuracy.
|
